Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00068133
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
2003-09-08
Brief Title:
Trial of VLTS-589 in Subjects With Intermittent Claudication
Sponsor:
Valentis
Organization:
Valentis
Study Overview
Official Title:
A Phase II Multicenter Double-Blind Placebo-Controlled Trial of VLTS-589 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease
Status:
COMPLETED
Status Verified Date:
2005-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and tolerability of VLTS-589 compared with placebo administered bilaterally to the lower extremities in subjects with intermittent claudication and to determine the effect of VLTS-589 in peak walking time PWT for subjects receiving VLTS-589 compared with subjects receiving placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None